These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 5021822)
1. [Experiences with the "Minipill"]. Meng M Schweiz Rundsch Med Prax; 1972 Apr; 61(16):519-31. PubMed ID: 5021822 [No Abstract] [Full Text] [Related]
2. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic]. de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370 [No Abstract] [Full Text] [Related]
3. Clinical and laboratory experience with a modified low dosage sequential oral contraceptive. Wamsteker EF Int J Fertil; 1968; 13(4):436-43. PubMed ID: 5700403 [No Abstract] [Full Text] [Related]
4. Compatibility of hormonal contraceptives in diabetics. Results of a questionnaire survey. Zeller WJ; Brehm H; Schöffling K; Melzer H Arzneimittelforschung; 1974 Mar; 24(3):351-7. PubMed ID: 4135187 [No Abstract] [Full Text] [Related]
12. Taiwan: first island-wide pill acceptor follow-up survey. Sun TH; Chen FL; Chang MC; Cernada GP Stud Fam Plann; 1970 Dec; 60():18-23. PubMed ID: 5521304 [No Abstract] [Full Text] [Related]
13. [Effect and tolerance of a low dose ovulation inhibitor (Orlest)]. Koester H; Hertel H Munch Med Wochenschr; 1969 Oct; 111(41):2103-9. PubMed ID: 5395280 [No Abstract] [Full Text] [Related]
14. [Varices and oral contraceptives. Is there a response to all the questions?]. Lorijn RH Phlebologie; 1991; 44(2):353-60; discussion 360-5. PubMed ID: 1946671 [No Abstract] [Full Text] [Related]
15. Canadian county-sponsored family planning. II. Twelve-month review. Tyson JE; Washburn HH; Tindale E Obstet Gynecol; 1967 Dec; 30(6):875-80. PubMed ID: 6061840 [No Abstract] [Full Text] [Related]
16. [Ovulation inhibition with low dosage gestagen components. Results of international clinical trial of Orlest]. Figoureux J; Onghena G; Schlikker E; Wattiez M; Schlösser W; Vercautere E; William P Munch Med Wochenschr; 1967 Dec; 109(48):2555-8. PubMed ID: 5631905 [No Abstract] [Full Text] [Related]
18. Oral contraceptives: technical and safety aspects. WHO Offset Publ; 1982; (64):1-45. PubMed ID: 7102094 [No Abstract] [Full Text] [Related]
19. [Sequential ovariostatic therapy with ethinyl estradiol associated with 6-dehydro-retro-progesterone. Comparative study of 2 different dosages]. Schockaert JA; De Cooman E Minerva Ginecol; 1968 Feb; 20(4):343-54. PubMed ID: 5738734 [No Abstract] [Full Text] [Related]
20. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Myer L; Denny L; Wright TC; Kuhn L Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]